Article
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
19 May 2022
Abstract excerpt
Abstract Cancer immunoediting 1 is a hallmark of cancer 2 that predicts that lymphocytes kill more immunogenic cancer cells to cause less immunogenic clones to dominate a population. Although proven in mice 1,3 , whether immunoediting occurs naturally in human cancers remains unclear. Here, to address this, we investigate how 70 human pancreatic cancers evolved over 10 years. We find that, despite having more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.